Israel Englander Logic Bio Therapeutics, Inc. Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.35 - $0.74 $17,599 - $37,210	-50,285 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $51,692 - $211,007	-84,742 Reduced 62.76%	50,285 $34,000
Q4 2021 Feb 14, 2022	BUY	$2.2 - $4.53 $190,229 - $391,700	86,468 Added 178.07%	135,027 $312,000
Q3 2021 Nov 15, 2021	SELL	$3.85 - $5.09 $176,156 - $232,892	-45,755 Reduced 48.51%	48,559 $222,000
Q2 2021 Aug 16, 2021	BUY	$4.03 - $7.57 $380,085 - $713,956	94,314 New	94,314 $419,000
Q1 2021 May 17, 2021	SELL	$6.8 - $9.16 $402,097 - $541,649	-59,132 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.29 - $9.1 $230,400 - $396,341	43,554 Added 279.59%	59,132 $451,000
Q3 2020 Nov 16, 2020	BUY	$5.41 - $9.45 $84,276 - $147,212	15,578 New	15,578 $141,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.